Suchergebnisse - "Viral Vaccines"

PubPharm (30.002)

61

Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor

enthalten in: Viruses | 2024

von Kim, J. | Park, S. | Lee, G. | +6

62

Recent advances in the treatment of Ebola disease : A brief overview

enthalten in: PLoS pathogens | 2024

von El Ayoubi, L. | Mahmoud, O. | Zakhour, J. | +1

63

Adoption of veterinary vaccines, determining factors, and barriers in Southwest Ethiopia : Implications for livestock health and disease management strategies

enthalten in: Preventive veterinary medicine | 2024

von Robi, D. | Bogale, A. | Temteme, S. | +2

64

mRNA-based monkeypox virus vaccine prevents disease in non-human primates

enthalten in: Cell | 2024

von Nitido, A. | Balazs, A.

65

Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults : Results From a Phase 1, Randomized, Clinical Trial

enthalten in: The Journal of infectious diseases | 2024

von Fierro, C. | Brune, D. | Shaw, M. | +9

66

Mucosal vaccines for viral diseases : Status and prospects

enthalten in: Virology | 2024

von Ma, B. | Tao, M. | Li, Z. | +3

67

Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice

enthalten in: Iranian journal of immunology : IJI | 2024

von Dashti, N. | Golsaz-Shirazi, F. | Jeddi-Tehrani, M. | +3

68

Immunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus

enthalten in: Scientific reports | 2024

von Nguyen, T. | Kim, H.

69

enthalten in: Ugeskrift for laeger | 2024

von Lichscheidt, E. | Harboe, Z. | Fischer, T. | +1

70

Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein

enthalten in: Viruses | 2024

von García-Cambrón, J. | Cerriteño-Sánchez, J. | Lara-Romero, R. | +5